Global Ankylosing Spondylitis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 158773
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 124
  • list Pharmaceuticals and Healthcare

Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15–30 years. 

Scope of the Report:

This report studies the Ankylosing Spondylitis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ankylosing Spondylitis Treatment market by product type and applications/end industries.

The ankylosing spondylitis treatment market is growing at a significant rate due to the increasing prevalence of ankylosing spondylitis and rising awareness about diagnostics and treatments for the disease. In addition, government initiatives and improving healthcare infrastructure are driving the market for ankylosing spondylitis treatment. However, factors such as the high cost of treatment and lack of skilled surgeons and physiotherapists restrain the market from growing.

The increasing prevalence of ankylosing spondylitis itself is a major factor impelling the global ankylosing spondylitis treatment market. In addition, factors such as rising awareness, technological advancements, government initiatives and improvement in the reimbursement scenario augur well for the global ankylosing spondylitis treatment market. However, factors such as high treatment costs and a dearth of experienced professionals are restraining the global ankylosing spondylitis treatment market. In addition, a low adoption rate of ankylosing spondylitis treatment options is restraining the market.

The global Ankylosing Spondylitis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ankylosing Spondylitis Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Abbvie

Amgen

Janssen Biotech

Merck

UCB

Boehringer Ingelheim

Johnson & Johnson

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Disease-Modifying Anitrheumatic Drugs (DMARDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Biologics

Market Segment by Applications, can be divided into

Juveniles

Adults

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Ankylosing Spondylitis Treatment Market Overview

1.1 Product Overview and Scope of Ankylosing Spondylitis Treatment

1.2 Classification of Ankylosing Spondylitis Treatment by Types

1.2.1 Global Ankylosing Spondylitis Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Ankylosing Spondylitis Treatment Revenue Market Share by Types in 2017

1.2.3 Disease-Modifying Anitrheumatic Drugs (DMARDs)

1.2.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

1.2.5 Biologics

1.3 Global Ankylosing Spondylitis Treatment Market by Application

1.3.1 Global Ankylosing Spondylitis Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Juveniles

1.3.3 Adults

1.4 Global Ankylosing Spondylitis Treatment Market by Regions

1.4.1 Global Ankylosing Spondylitis Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Ankylosing Spondylitis Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Abbvie

2.1.1 Business Overview

2.1.2 Ankylosing Spondylitis Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbvie Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen

2.2.1 Business Overview

2.2.2 Ankylosing Spondylitis Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Janssen Biotech

2.3.1 Business Overview

2.3.2 Ankylosing Spondylitis Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Janssen Biotech Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Merck

2.4.1 Business Overview

2.4.2 Ankylosing Spondylitis Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merck Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 UCB

2.5.1 Business Overview

2.5.2 Ankylosing Spondylitis Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 UCB Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 Boehringer Ingelheim

2.6.1 Business Overview

2.6.2 Ankylosing Spondylitis Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Boehringer Ingelheim Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.7 Johnson & Johnson

2.7.1 Business Overview

2.7.2 Ankylosing Spondylitis Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Johnson & Johnson Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Ankylosing Spondylitis Treatment Market Competition, by Players

3.1 Global Ankylosing Spondylitis Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Ankylosing Spondylitis Treatment Players Market Share

3.2.2 Top 10 Ankylosing Spondylitis Treatment Players Market Share

3.3 Market Competition Trend

4 Global Ankylosing Spondylitis Treatment Market Size by Regions

4.1 Global Ankylosing Spondylitis Treatment Revenue and Market Share by Regions

4.2 North America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

5 North America Ankylosing Spondylitis Treatment Revenue by Countries

5.1 North America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)

5.2 USA Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

6 Europe Ankylosing Spondylitis Treatment Revenue by Countries

6.1 Europe Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)

6.2 Germany Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

6.4 France Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Ankylosing Spondylitis Treatment Revenue by Countries

7.1 Asia-Pacific Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)

7.2 China Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

7.5 India Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

8 South America Ankylosing Spondylitis Treatment Revenue by Countries

8.1 South America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)

8.2 Brazil Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Ankylosing Spondylitis Treatment by Countries

9.1 Middle East and Africa Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)

10 Global Ankylosing Spondylitis Treatment Market Segment by Type

10.1 Global Ankylosing Spondylitis Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Ankylosing Spondylitis Treatment Market Forecast by Type (2018-2023)

10.3 Disease-Modifying Anitrheumatic Drugs (DMARDs) Revenue Growth Rate (2013-2023)

10.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth Rate (2013-2023)

10.5 Biologics Revenue Growth Rate (2013-2023)

11 Global Ankylosing Spondylitis Treatment Market Segment by Application

11.1 Global Ankylosing Spondylitis Treatment Revenue Market Share by Application (2013-2018)

11.2 Ankylosing Spondylitis Treatment Market Forecast by Application (2018-2023)

11.3 Juveniles Revenue Growth (2013-2018)

11.4 Adults Revenue Growth (2013-2018)

12 Global Ankylosing Spondylitis Treatment Market Size Forecast (2018-2023)

12.1 Global Ankylosing Spondylitis Treatment Market Size Forecast (2018-2023)

12.2 Global Ankylosing Spondylitis Treatment Market Forecast by Regions (2018-2023)

12.3 North America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)

12.6 South America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Ankylosing Spondylitis Treatment Picture

Table Product Specifications of Ankylosing Spondylitis Treatment

Table Global Ankylosing Spondylitis Treatment and Revenue (

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery